Skip to main content
Home

GBL

Main navigation

  • About GBL
      About GBL
    • Our purpose
    • Shareholding
    • Governance
      • Board of Directors
      • Board Committees
      • Corporate governance
    • ESG
      • Sustainability
      • GBL ACT
    • Risk Management
    • Business model
  • Portfolio
      Portfolio
    • Listed assets
      • 55% of GBL’s portfolio
      • adidas
      • Concentrix
      • Imerys
      • Ontex
      • Pernod Ricard
      • SGS
      • Umicore
    • Direct private assets
      • 24% of GBL’s portfolio
      • Affidea
      • Canyon
      • Parques Reunidos
      • Sanoptis
      • Voodoo
    • Indirect private assets
      • 20% of GBL’s portfolio
      • Funds
      • Co-investments
    • Third-party asset management
      • 1% of GBL’s portfolio
  • Investors
      Investors
    • GBL Share
      • Stock price & key share information
      • Dividend
      • Total Shareholder Return
      • Capital and form of shares
      • Voting rights and denominator
      • Transactions on GBL shares
    • Key Financial Information
      • Net asset value
      • Net financial position
      • Credit rating
      • Consolidated net result & Cash earnings
      • Glossary
    • Analysts
    • General Meeting
    • Financial Calendar
    • Strategic Update
    • Prospectus
  • Culture & Careers
  • Media Center
      Media Center
    • Press releases
    • Annual & Half-year reports
    • IR Presentations
    • Analyst Presentations
    • Voting rights and denominator
    • Transactions on GBL shares
    • Subscription Form
71.65 €
Stock price
05/13/202514:15
GBL Share

Stock price & key share information

Key share information

(as of December 31, 2024)
  • Total number of shares outstanding: 138,400,000
  • Fully paid-up share capital: EUR 653.1 million
  • All shares are entitled to dividends(1) and voting rights, and since 2020, the Company has granted double voting rights under certain conditions(2). Voting rights linked to GBL shares held by the Company or by its direct and indirect subsidiaries are suspended.
  • Market capitalization: EUR 9.1 billion
  • Listed on the Euronext Brussels stock exchange
  • Included in the BEL20 index, which represents the 20 largest listed companies in Belgium. With a weight of 5.2%, GBL is the 6th largest company in the index.
  • Included in the STOXX Europe 600 Financial Services index. With a weight of 1.1%, GBL is the 16th largest company in the index.
  • RIC: GBLB.BR
  • Bloomberg: GBLB BB


(1) Excluding Treasury shares held by Groupe Bruxelles Lambert SA
(2) Double voting rights are granted to GBL shares that have been registered for at least two years, without interruption, in the name of the same shareholder in GBL’s register of registered shares

Scroll to content

Main navigation

  • About GBL
      About GBL
    • Our purpose
    • Shareholding
    • Governance
      • Board of Directors
      • Board Committees
      • Corporate governance
    • ESG
      • Sustainability
      • GBL ACT
    • Risk Management
    • Business model
  • Portfolio
      Portfolio
    • Listed assets
      • 55% of GBL’s portfolio
      • adidas
      • Concentrix
      • Imerys
      • Ontex
      • Pernod Ricard
      • SGS
      • Umicore
    • Direct private assets
      • 24% of GBL’s portfolio
      • Affidea
      • Canyon
      • Parques Reunidos
      • Sanoptis
      • Voodoo
    • Indirect private assets
      • 20% of GBL’s portfolio
      • Funds
      • Co-investments
    • Third-party asset management
      • 1% of GBL’s portfolio
  • Investors
      Investors
    • GBL Share
      • Stock price & key share information
      • Dividend
      • Total Shareholder Return
      • Capital and form of shares
      • Voting rights and denominator
      • Transactions on GBL shares
    • Key Financial Information
      • Net asset value
      • Net financial position
      • Credit rating
      • Consolidated net result & Cash earnings
      • Glossary
    • Analysts
    • General Meeting
    • Financial Calendar
    • Strategic Update
    • Prospectus
  • Culture & Careers
  • Media Center
      Media Center
    • Press releases
    • Annual & Half-year reports
    • IR Presentations
    • Analyst Presentations
    • Voting rights and denominator
    • Transactions on GBL shares
    • Subscription Form

Groupe Bruxelles Lambert (GBL)

Avenue Marnix 24
B-1000 Brussels

Contact

Reception
+32 2 289 17 86
cdumasy@gbl.com

Investor Relations

Alison Donohoe
+32 2 289 17 64
adonohoe@gbl.com
 

© 2025 GBL, all rights reserved

Footer Menu

  • Legal Notice
  • General Privacy Policy
  • Cookie policy

Made by Globule Bleu